Navigation Links
InaVein, LLC Announces First Peer-reviewed Publication of TRIVEX® Used In-Office
Date:10/20/2011

LEXINGTON, Mass., Oct. 20, 2011 /PRNewswire/ -- InaVein, LLC today announced publication of a peer-reviewed paper that examines use of the TRIVEX transilluminated powered phlebectomy (TIPP) System for removal of varicose veins in a clinical office rather than a hospital setting. The paper, Transilluminated Powered Phlebectomy in an Office Setting:  Procedural Considerations and Clinical Outcomes was authored by Gregory A. Spitz, M.D., FACS (AmeriVein Systems, Aurora, Illinois) and published in the October 2011 edition of the Journal of Endovascular Therapy.  The TRIVEX procedure was successfully completed on all patients using only local tumescent anesthesia.  There were no reports of hematomas, deep vein thrombosis, or extended parasthesia at the 3-month follow up.  Patients reported a high level of satisfaction (9.6 out of 10) in this setting. A mean procedure time of 13.5 minutes (+/-3.7 min) was reported.  Thirty-three of the 36 patients underwent concurrent endovenous ablation procedures.  According to Dr. Spitz, "More recent cases have confirmed that when patients are prepared for an in-office procedure and treated by a physician well versed in the TIPP procedure and tumescent anesthesia, the outcomes are mutually satisfying. There should also be an economic benefit, with reduced cost to the healthcare system, as has been realized in other clinical situations."  InaVein CEO Keith Jansen said, "This clinical evidence highlights the benefits of the TRIVEX procedure in an office environment for patients who have varicose veins -- a condition that impacts 25 - 40 million Americans and over 700 million people globally."

About InaVein

InaVein, LLC is a privately held company engaged in the development, manufacture, marketing and commercialization of unique medical devices for the treatment of vein disease. The company's flagship product, The TRIVEX System, is the first technology to provide vein specialists with a minimally invasive technique to remove varicose veins safely and efficiently under direct vision. Since 2003, thousands of patients worldwide have been successfully treated using The TRIVEX System in a surgical setting to completely remove their varicose veins.

For more information please contact:
InaVein, LLC
Keith Jansen
President & CEO
617.245.1965 ext. 1102
Email: kjansen@inavein.com

Website: www.inavein.com


'/>"/>
SOURCE InaVein, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Epilepsy Therapy Project Announces "Shark Tank" Competition to Identify the Most Innovative, New Products for People with Epilepsy
2. China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc.
3. Misonix Announces the Sale of Its Laboratory and Forensic Safety Products Business for $1.5 Million
4. The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® to Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery
5. WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System
6. Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call
7. Bend Research Announces New Chief Financial Officer
8. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Nine-Months Ended September 30, 2011 and Declares Quarterly Dividend
9. Amgen Announces Webcast of 2011 Third Quarter Financial Results
10. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
11. Robertson Global Health Solutions Announces Commercial Venture with Telemedicine Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
Breaking Medicine Technology:
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... Middletown, PA (PRWEB) , ... February 12, 2016 , ... ... year’s event will be held in Anaheim, CA at the Anaheim Convention Center. Almost ... they can see new therapy products in action, learn more about their chosen field ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... firm announced that nominations have closed for the ISE Southeast Awards 2016. Finalists ... be announced at the ISE® Southeast Executive Forum and Awards Gala on March ...
(Date:2/12/2016)... ... 12, 2016 , ... Every winter, someone is killed, injured or loses a ... Burn Center, part of the Allegheny Health Network, has partnered with Etna Volunteer ... Heaters Need Space” campaign. , “Space Heaters Need Space” aims to bring ...
Breaking Medicine News(10 mins):